 1. Determine if a 20 reduction in global longitudinal strain by echocardiography can predict subsequent composite cardiotoxicity in a collection of patients with either HER2- breast cancer, sarcoma, or lymphoma receiving modern chemotherapy regimens containing anthracyclines. 